Effects of Mast Cell Growth Factor on Ara-C Mediated Acute Myeloid Leukemia Cell Killing
|
|
- Roger Hampton
- 5 years ago
- Views:
Transcription
1 Effects of Mast Cell Growth Factor on Ara-C Mediated Acute Myeloid Leukemia Cell Killing A. Tafuri, L. De Felice, M. G. Mascolo, T. Valentini, M. T. Petrucci, M. C. Petti University La Sapienza of Rome, Hematology, Department of Biopathology, Rome, taly Key Words. AML Ara-C MGF Growth factors Abstract. Cell kinetic studies of acute myeloid leukemia (AML) have provided evidence for the presence of nonproliferating cells. Hemopoietic growth factors (GF) can regulate proliferation of leukemic cells, furnishing new possibilities for recruiting quiescent cells into the cycle and overcoming cytokinetic resistance in AML. To assess the role of the novel identified cytokine, mast cell growth factor (MGF), in enhancing cytosine arabinoside (Ara-C) cytotoxicity, we have primed AML blasts with MGF and then exposed these cells to the S phase specific agent Ara-C. Other growth factors such as PXY, interleukin 3 (L-3), granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte CSF (G-CSF) and the combination of MGF plus PXY were also tested. Cytokinetic changes and clonogenic growth of leukemic colony forming unit (CFU-L) cells in methylcellulose were used to detect proliferative and cytotoxic effects on AML blasts. Expression of MGF receptor, the c-kit protein, was also measured by flow cytometry. We report in this preliminary study that MGF is able to increase proliferation in 75% of the samples studied and enhance Ara-C cytotoxicity in some of these cases. When MGF proliferative activity was compared with other GFs, individual cases showed heterogeneity in response, although the combination of MGF plus PXY was always the most effective. ntroduction Cell kinetic analysis of acute myeloid leukemia (AML) has identified a substantial Correspondence: Dr. Agostino Tafuri, Laboratory of Cell Kinetics, Department of Biopathology, University La Sapienza of Rome, Via Benevento 6, Rome, taly. Received March 9, 1993; accepted for publication March 9, OAlphaMed Press /93/$5.00/0 number of nonproliferating or very slowly proliferating blast cells [ 13. Their presence may play an important role in kinetic resistance to chemotherapy, which is usually aimed against cycling cells. Laboratory studies have suggested that hemopoietic growth factors (GFs), when combined with cytosine arabinoside (Ara-C), can enhance cytotoxic effects of this agent against AML cells [2]. Granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin 3 (L-3) can increase the percentage of cells in S phase recruiting Go cells and enhance Ara-C cytotoxic effects against AML blasts [3-51. We demonstrated that a combination of GM-CSF plus a -3 had a greater in vitro effect in decreasing quiescent cells versus treatment with the individual GF alone [5]. The GM-CSF/L-3 fusion protein has been recently referred to as the most effective in induction of proliferation of AML blasts and normal progenitors [6]. Mast cell growth factor (MGF) is a recently identified cytokine which acts on primitive hemopoietic precursors [7] through a specific receptor, the protein encoded by the proto-oncogene c-kit [8]. Expression of this receptor in AML blast cells [9] and preliminary reports of mitogenic activity of MGF on myeloid leukemia cells [ 101 indicate that MGF may play a role in the growth and proliferation of myeloid leukemic cells. Therefore, we investigated in this study the cell kinetic changes and the clonogenic blast cell proliferation induced by MGF in myeloid leukemia in order to detect effects on Ara-C cytotoxicity using this combined MGF/Ara-C strategy. Comparison of proliferative activity between MGF and other growth factors was also studied along with pattern of c-kit receptor expression. STEM CELLS 1993;11(~Uppl2):88-92
2 Tafuri et al. 89 Materials and Methods Samples Peripheral blood and bone marrow samples were obtained with informed consent, according to institutional policy, from four AML patients. Patient characteristics are listed in Table. Mononuclear cells were separated by Ficoll- Hypaque density gradient. Biological Reagents Recombinant human MGF and PXY 32 1 (GM-CSFLL-3 fusion protein) were kindly provided by mmunex, Seattle, WA, and were used respectively at a concentration of 50 ng/ml and 10 ng/ml. L-3 (Sandoz) was used at 20 ng/ml, GM-CSF and granulocyte CSF (G-CSF) at 500 U/ml (respectively from Schering and Roche, Basel, Switzerland). Suspension Culture Blast cells were resuspended in RPM supplemented by 10% fetal calf serum (FCS), 1% L-glutamine and 1 % penicillin-streptomycin (all from GBCO, Grand sland, NY). The number was adjusted to a starting concentration of 1.O x lo6 cells/ml. Cells were cultured for 48 h at 37 C in 5% C02 with and without (control culture) the following growth factors: MGF, PXY, G-CSF, GM-CSF, L-3, and MGF + PXY. Afterwards, cell number/viability was assessed by trypan blue exclusion. At this time kinetic studies and clonogenic assay were performed (see below). Cytotoxic Drug Effects After 48 h of incubation with cytokine, Ara-C (10 pm, 1 pm, 0.01 pm) was added to suspension cultures for 24 h. Cytotoxicity was determined by clonogenic assay in methylcellulose, and the results were expressed as the percentage of clonogenic cells killed at different Ara-C concentrations. Table. AML patient characteristics FAB Sample WBC/mrn3 Blasts(%) #1 M4E PB 19, #2 M5a BM 1, #3 M3 PB 24, #4 MO PB 23, Clonogenic Assay To measure cytokine-induced proliferative changes in clonogenic cells and changes in Ara-C cytotoxic effects, cultures were performed using the leukemic colony forming unit (CFU-L) assay, previously described [ 111. Cells were seeded at a density of lo5 in 1 ml MDM, 30% FCS, 0.8% methylcellulose and 10% 5637-culture medium (CM). Plates were scored for clusters (>8 cells) and colonies (>20 cells) after 7 days of incubation. Results are expressed as total number of clusters and colonies. Kinetic Studies To evaluate cell cycle distribution, flow cytometric acridine-orange (A.O.) technique was performed, as previously described [12]. A.O. was used to measure cellular DNA and RNA content (percentage of cells in Go, G, S, G2M, mean RNA content). The RNA content of G cells was expressed as RNA-index (RNA- G) determined as the ratio of mean RNA content of G cells of the samples times ten, divided by the median RNA content of control lymphocytes. Receptor Studies ndirect immunofluorescence for staining with the anti-kit antibody, clone 17F11 (mmunotech, S.A., Marseille, France) was performed as previously described [ 101 and then measured by flow cytometry. Flow Cytometric Measurement and Analysis A modified fluorescence activated cell sort (FACScan; Becton Dickinson, San Jose, CA) was used to measure fluorescence upon excitation at 488 nm. For each analysis 5-10 x lo3 cells were measured at separate wavelengths for green (F530-DNA [A.O.] FTC) and red (F > 620-RNA [A.O.]). Samples were analyzed using Becton Dickinson software, including CellFit and Lysis 11. Results AML blast proliferation induced by MGF was studied measuring cell cycle kinetic changes and clonogenic cell growth. Cell Kinetic Effects and c-kit Expression Table 1 shows the cell cycle distribution of the four samples studied after 48 h of liquid
3 ~ 90 Effects of MGF on Ara- C Cytotoxicity in AML Table 11. Cell cycle effects # GO% G% S% RNA- G c-kit% 1 -Control 26.9 MGF Control 53.0 MGF Control 35.1 MGF Control 93.0 MGF o n.d n.d n.d culture with and without cytokines. MGF induces recruitment into the cycle in 3/4 samples (#l, #2, #4) (see Fig. 1) with significant decrease (>25%) of Go cells and increase in S phase, only in sample #1 the changes in S phase were minor although proliferation was already high in the control culture. A different degree of response was seen in each case: Go cells decreased from to 3.05-fold, and S phase cells exhibited an increase from to 5-fold. Sample #3 failed to show any changes in the MOF Rna cell cycle distribution. Receptor studies for MGF demonstrated c-kit protein expression only in 113 of responder cases (#4). When proliferative activity induced by MGF was compared with other growth factors, the greatest decrease in Go cells and increase in S phase was induced by the combination of MGF plus PXY 321, and the last one was the more active among the single cytokines studied. Effect of MGF on Clonogenic Cell Growth Three out of four samples studied showed clonogenic growth (#l, #2, #4) (see Fig. 2). A significant (>30%) proliferative response to MGF priming was detected in 213 cases (#2, #4) as shown in Table 111. When the effect of MGF was compared with other cytokines, heterogeneity in response was seen in individual cases. Low proliferative effects were induced by both MGF and other GFs in sample #1 (MGF: 1.3-fold, MGF + PXY: 1.4-fold). Higher growth response to GFs was seen for case #2 (MGF: DDWJ MQF DXY Fig. 1. Cell kinetic effects of MGF, L-3, PXY and MGF + PXY in aneuploid AML sample as measured by A.O. flow cytometric technique. Significant recruitment of leukemic quiescent cells is apparent for all conditions, especially for MGF and MGF + PXY. Fig. 2. Clonogenic cell growth of three AML samples (#1. #2, #4). Comparison between control cultures (black bar) and MGF exposed cultures.
4 Tafuri et al. 91 Table 111. Effect of MGF on CFU-L growth #1 #2 #4 Control 1,901 5, MGF 2,391 26, clusters + colonies/los plated cells 4.6-fold, MGF + PXY 4.5-fold). n the third case (#4), G-CSF was the most effective single growth factor (4.7-fold), and MGF combined with PXY showed a synergistic proliferative effect (1 1.4-fold). Effects of MGF on Ara-C Cytotoxicity A correlation between MGF proliferative effects and Ara-C sensitization of leukemic progenitors was found in all cases. As shown in Table V, in samples with increased clonogenic growth after exposure to MGF (#2 and #4), a significant enhancement of CFU-L killing was detected at 1 pm Ara-C (58% versus 1% and 100% versus 29.6%). A similar correlation was also found at 0.01 pm Ara-C (23% and 56% versus 0). Sample #1 failed to show a significant increase in clonogenic cell growth, and the percentage of clonogenic cell killing appeared reduced after MGF exposure. We should notice that in this sample sensitivity to Ara-C in the control culture was already maximal (99.6% and 92.5% respectively at 10 ph4 and 1 N). Discussion n this study we investigated in vitro proliferative effects induced by MGF on AML blast Table V. MGF induced changes in Ara-C cytotoxicity Ara-C la.01 pm 1-Control MGF Control MGF Control MGF % of killed CFU-L cells in order to determine changes in Ara-C cytotoxicity through a kinetic mechanism. Our preliminary data suggest that MGF is able to stimulate leukemia cell proliferation in the majority (75%) of the samples, although heterogeneity is apparent in individual cases. Recent reports [ 101 confirm the importance of MGF as a growth factor on myeloid leukemia cells, either as a direct stimulus or as a synergistic factor. Under the experimental conditions tested in this study, the combination of MGF and PXY induced the highest proliferation with synergistic effects detected by flow cytometric andfor clonogenic assay. The absence of detectable levels of flow cytometric c-kit protein in some of the responder samples showed a reduced sensitivity of this technique, confirming that more sensitive assays (i.e., Scatchard analysis) are required to detect SCF receptors in AML cases, as recently published [13]. Our data further suggests that MGF is effective in terms of Ara-C sensitization in some of the AML samples. A correlation was found between proliferative response to MGF and enhancement of Ara-C cytotoxic effects since in all cases with a significant increase in clonogenic cell growth, the highest percentage of CFU-L inhibition was detected. The only sample in which Ara-C sensitization after MGF exposure was not detected, was characterized by an already high value of S phase in the control culture; therefore, as reported for other cytokines [5], no further increase in proliferation could be detected. Several mechanisms have been reported to explain the effectiveness of the strategy of combined cytokine chemotherapy. A kinetic effect on quiescent cells has been described for other cytokines [5], and the present study suggests that the same mechanism also can be involved for MGF. Further studies are necessary to evaluate this preliminary in vitro observation on MGFlAra-C sensitization with careful evaluation of 1) beneficial net gain in cell killing (balance between expansion of leukemic cells and enhanced cell killing); and 2) biological features of leukemic cells at diagnosis that may be harmful if the leukemic population is increased by GFs (drug resistance). The role of MGF in stimulating residual normal progenitor proliferation in acute leukemia should also be established. MGF alone has been reported to be a poor stimulator of committed normal progenitors where a strong synergistic
5 92 Effects of MGF on Ara- C Cytotoxicity in AML activity in combination with other cytokines was found [ 141. t is therefore mandatory to evaluate the kinetic effects on normal progenitors when MGF is combined with other cytokines and chemotherapeutic drugs in acute leukemia. Acknowledgments The authors wish to thank Dr. Steven Gillis from mmunex, Seattle, WA, for kindly providing MGF and PXY 321. References 1 Clarkson BD, Fried J, Sakai Y, Ohkita T. Studies of cellular proliferation in human leukemia Behavior of leukemic cells in three adults with acute leukemia given continuous infusion of,h-thymidine for 8 or 10 days. Cancer 1970;25: Andreeff M, Welte K. Hemopoietic colony stimulating factors. Semin Oncol 1989;16: Lista P, Porcu P, Avanzi GC, Pegoraro L. nterleukin-3 enhances the cytotoxic activity of 1 -beta-d arabinofuranosylcytosine (Ara-C) on acute myeloblastic leukemia (AML) cells. Br J Hematology 1988;69: Cannistra SA, Groshek P, Griffin JD. Granulocyte-macrophage colony stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia. Leukemia 1989;3: Tafuri A, Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 1990;12: Williams DE, Park LS. Hemopoietic effects of a granulocyte macrophage colony stimulating factorlinterleukin-3 fusion protein. Cancer 1990;67: Zsebo K, Wypych J, McNiece, Lu H, Smith K, Karkare S, Sachdev R, Yuschenkoff V, Birkett N, Williams L, Satyagal V, Tung W, Bosselman B, Mendaiaz E, Langley K. dentification, purification, and biological characterization of hematopoietic stem cell factor from Buffalo rat liver conditioned medium. Cell 1990;63: Chabot B, Stephenson DA, Chapman VM, Besner P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse Wlocus. Nature 1988;144: Wang C, Koistinen P, Yang GS, Williams DE, Lyman SD, Minden MD, McCulloch EA. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 1991;5: Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo K, Welte K. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hemopoietic growth factors. Blood 1992;80: Buick RN, Till JE, McCulloch EA. Colony assay for proliferative blast cells circulating in myeloblastic leukemia. Lancet 1977;i: Andreeff M, Darzynkiewicz Z, Sharpless TK, Clarkson BD, Melamed MR. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 1980;55: Broudy VC, Smith FO, Lin N, Zsebo K, Egrie J, Bernstein D. Recombinant human stem cell factor (rhuscf) stimulates the growth of hemopoietic colonies from patient with acute nonlymphocytic leukemia (ANL) by binding to a specific receptor. Blood 1990;76:134a. 14McNiece K, Langley KE, Zsebo KM. Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, L-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 1991;19:
CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow
White Paper September 2016 CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow Lily C. Trajman, PhD Introduction: Hematopoietic Stem Cells (HSCs)
More informationEffect of Interleukin 10 on the Hematopoietic Progenitor Cells from Patients with Aplastic Anemia
Effect of Interleukin 10 on the Hematopoietic Progenitor Cells from Patients with Aplastic Anemia YOSHINOBU ASANO, SHOICHIRO SHIBATA, SHINJI KOBAYASHI, SEIICHI OKAMURA, YOSHIYUKI NIHO First Department
More informationFeasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas
University of Groningen Feasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas IMPORTANT NOTE: You are advised to consult the publisher's version
More informationTHE INFLUENCE OF SODIUM FLUORIDE ON THE CLONOGENECITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS: PRELIMINARY REPORT
168 Fluoride Vol. 33 No. 4 168-173 2 Research Report THE INFLUENCE OF SODIUM FLUORIDE ON THE CLONOGENECITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS: PRELIMINARY REPORT Boguslaw Machaliński, a Maria Zejmo,
More informationEML Erythroid and Neutrophil Differentiation Protocols Cristina Pina 1*, Cristina Fugazza 2 and Tariq Enver 3
EML Erythroid and Neutrophil Differentiation Protocols Cristina Pina 1*, Cristina Fugazza 2 and Tariq Enver 3 1 Department of Haematology, University of Cambridge, Cambridge, UK; 2 Dipartimento de Biotecnologie
More informationInternational Journal of Cell Cloning (1991)
Concise Review International Journal of Cell Cloning 9542-547 (1991) Hybrid Cytokines as Hematopoietic Growth Factors Douglas E. Williamsa, Linda S. Park", Hal E. Broxmeyerb, Li Lub 'Immunex Research and
More informationInterleukin-l Production in Patients with Nonlymphocytic Leukemia and Myelodysplastic Syndromes
Interleukin-l Production in Patients with Nonlymphocytic Leukemia and Myelodysplastic Syndromes N. J. Simbirtseva 1 A common feature of all cases of myeloid leukemia is a block in normal maturation of
More informationChemotherapeutic Susceptibility of Human Bone Marrow Progenitor Cells and Human Myelogenous Leukemia Cells (HMO) in Co-Culture: Preliminary Report
International Journal of Cell Cloning 2: 254-262 (1984) Chemotherapeutic Susceptibility of Human Bone Marrow Progenitor Cells and Human Myelogenous Leukemia Cells (HMO) in Co-Culture: Preliminary Report
More informationRapid Decline of Clonogenic Hemopoietic Progenitors in Semisolid Cultures of Bone Marrow Samples Derived from Patients with Chronic Myeloid Leukemia
Original Manuscript International Journal of Cell Cloning 7314-321 (1989) Rapid Decline of Clonogenic Hemopoietic Progenitors in Semisolid Cultures of Bone Marrow Samples Derived from Patients with Chronic
More informationEffects of Prostaglandin E on the Proliferation and Differentiation of Leukemic Progenitor Cells in Acute Nodymphocytic Leukemia
International Journal of Cell Cloning 1 : 440-450 (1983) Effects of Prostaglandin E on the Proliferation and Differentiation of Leukemic Progenitor Cells in Acute Nodymphocytic Leukemia Keiya Ozawa&.l,
More informationMcAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells
Effects of McAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells X.C. Wei, D.D. Yang, X.R. Han, Y.A. Zhao, Y.C. Li, L.J. Zhang and J.J. Wang Institute of hematological research,
More informationMATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All
MATERIALS AND METHODS Antibodies (Abs), flow cytometry analysis and cell lines Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All other antibodies used
More informationDISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS
DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS James Clinton, Ph.D. Scientist, ATCC February 19, 2015 About ATCC Founded in 1925, ATCC is a non-profit
More informationIn Vitro Effect of Stem Cell Factor on Colony Growth from Acquired Severe Aplastic Anemia
In Vitro Effect of Stem Cell Factor on Colony Growth from Acquired Severe Aplastic Anemia A. Bacigalupo," G. Piaggio," M. Podestd," M. R. Raffo," E. Tedone," G. Sogno," E Benvenuto,". Figari," L. Grassia,"
More informationStem cells: units of development and regeneration. Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research.
Stem cells: units of development and regeneration Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research Concepts 1. Embryonic vs. adult stem cells 2. Hematopoietic stem
More informationStem cells and Cancer. John Glod. December 2, 2009
Stem cells and Cancer John Glod Lehigh University Lehigh University December 2, 2009 The Tumor Microenvironment Littlepage et al Cancer Cell 2005 Cancer Stem Cells A small group of cells within the larger
More informationHemopoietic Precursors in Human Bone Marrow Transplantation
International Journal of Cell Cloning 4: 11-18 Suppl 1 (1986) Hemopoietic Precursors in Human Bone Marrow Transplantation H.A. Messner Ontario Cancer Institute, University of Toronto, Toronto, Ontario,
More informationIn Vitro Growth of Erythropoietic Progenitor Cells in Long-%rm Remission of Acute Leukemia
International Journal of Cell Cloning 4: 186-191 (1986) In Vitro Growth of Erythropoietic Progenitor Cells in Long-%rm Remission of Acute Leukemia C. Peschel, G. Konwalinka, D. Geissler, H. Bmunsteiner
More informationDevelopment of Natural Killer Cells from Lymphohematopoietic Progenitors of Murine Fetal Liver
Development of Natural Killer Cells from Lymphohematopoietic Progenitors of Murine Fetal Liver YUKHI AIBA, MAKIO OGAWA Ralph H. Johnson Department of Veterans Affairs Medical Center, Department of Medicine,
More informationEx vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2*
Ex vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2* 1 Department of Laboratory Medicine - Laboratory of Hematology, Radboud University
More informationAnnabel Strife, Amaury Perez, Caryl Lambek, David Wisniewski, Silvia Bruno, Zbigniew Darzynkiewicz, and Bayard Clarkson 2
[CANCER RESEARCH 53,401-409, Januau' 15, 1993] Characterization of Lineage-negative Blast Subpopulations Derived from Normal and Chronic Myelogenous Leukemia Bone Marrows and Determination of Their Responsiveness
More informationCan we classify cancer using cell signaling?
Can we classify cancer using cell signaling? Central hypotheses (big ideas) Alterations to signaling genes would cause leukemic cells to react in an inappropriate or sensitized manner to environmental
More informationAutomated and Standardized Counting of Mouse Bone Marrow CFU Assays
Automated and Standardized Counting of Mouse Bone Marrow CFU Assays 2 Automated and Standardized Colony Counting Table of Contents 4 Colony-Forming Unit (CFU) Assays for Mouse Bone Marrow 5 Automated Assay
More informationAcute myeloid leukemia. M. Kaźmierczak 2016
Acute myeloid leukemia M. Kaźmierczak 2016 Acute myeloid leukemia Malignant clonal disorder of immature hematopoietic cells characterized by clonal proliferation of abnormal blast cells and impaired production
More informationThe Two-step Liquid Culture: A Novel Procedure for Studying Maturation of Human Normal and Pathological Erythroid Precursors
The Two-step Liquid Culture: A Novel Procedure for Studying Maturation of Human Normal and Pathological Erythroid Precursors E. Fibach, E. A. Rachmilewitz Department of Hematology, Hadassah University
More informationLeukine. Leukine (sargramostim) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)
More informationInternational Journal of Cell Cloning 6: (1988) Research Laboratory of Blood Physiology, Hunan Medical College, Changsha, Hunan, PRC
Original Paper International Journal of Cell Cloning 6:290-295 (1988) The Influence of Histamine at Various Concentrations on the Cell Cycle State of Hematopoietic Stem Cells (CF'U-s) I"i Shounan, XU You-Heng
More informationNature Immunology: doi: /ni.3412
Supplementary Figure 1 Gata1 expression in heamatopoietic stem and progenitor populations. (a) Unsupervised clustering according to 100 top variable genes across single pre-gm cells. The two main cell
More informationHematopoiesis. BHS Liège 27/1/2012. Dr Sonet Anne UCL Mont-Godinne
Hematopoiesis BHS Liège 27/1/2012 Dr Sonet Anne UCL Mont-Godinne Hematopoiesis: definition = all the phenomenons to produce blood cells Leukocytes = White Blood Cells Polynuclear = Granulocytes Platelet
More informationVUmc Basispresentatie
Clinical diagnostic cytometry Gerrit J Schuurhuis Dept of Hematology VU University Medical Center Amsterdam, Netherlands Use of immunophenotyping at diagnosis to trace residual disease after therapy 1.
More informationInhibition of Mwine CFU-C by Vindesine: Restoration of Colony Growth by Colony Stimulating Factor
International Journal of Cell Cloning 1: 142-150 (1983) Inhibition of Mwine CFU-C by Vindesine: Restoration of Colony Growth by Colony Stimulating Factor Giuseppe Pigoli, Lina Mangoni, Cecilia CaFamatti,
More informationMPL W515L K mutation
MPL W515L K mutation BCR-ABL genotyping The exact chromosomal defect in Philadelphia chromosome is a translocation. Parts of two chromosomes, 9 and 22, switch places. The result is a fusion gene, created
More informationLeukine. Leukine (sargramostim) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.08 Subject: Leukine Page: 1 of 5 Last Review Date: September 15, 2017 Leukine Description Leukine
More informationNature Genetics: doi: /ng Supplementary Figure 1
Supplementary Figure 1 MSI2 interactors are associated with the riboproteome and are functionally relevant. (a) Coomassie blue staining of FLAG-MSI2 immunoprecipitated complexes. (b) GO analysis of MSI2-interacting
More informationLeukine. Leukine (sargramostim) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.08 Subject: Leukine Page: 1 of 6 Last Review Date: March 13, 2014 Leukine Description Leukine (sargramostim)
More informationDifferentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia"
Differentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia" Hoelzer, D.,l, Harriss, E. B.l, Kurrle, E.l, Schmücker, H.l, Hellriegel,
More informationTargeting CD123 in Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs )
Targeting CD123 in Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ) Muneera AL Hussaini 1, Julie Ritchey 1, Linda Eissenberg 1, Geoff Uy 1, Mike Rettig 1, Matthew Holt 1, Gurunadh
More informationCase 089: Therapy Related t(8;21)(q22;q22) AML and
Case 089: Therapy Related t(8;21)(q22;q22) AML and SM-AHNMD ST Pullarkat 1, V Pullarkat 2, SH Kroft 3, CS Wilson 4, M Thein 5, WW Grody 1, and RK Brynes 5 1 UCLA, 2 City of Hope National Med Ctr, 3 Med
More informationDone By : WESSEN ADNAN BUTHAINAH AL-MASAEED
Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We
More informationOncolytic Immunotherapy: A Local and Systemic Antitumor Approach
Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic immunotherapy Oncolytic immunotherapy the use of a genetically modified virus to attack tumors and induce a systemic immune response
More informationIntroduction STEM CELLS 1994;12:
Growth Factor Stimulation of Cryopreserved CD34 Bone Marrow Cells Intended for Transplant: An In Vitro Study to Determine Optimal Timing of Exposure to Early Acting Cytokines Mariusz Z. Ratajczak, Janina
More informationBCR-ABL - LSK BCR-ABL + LKS - (%)
Marker Clone BCR-ABL + LSK (%) BCR-ABL + LKS - (%) BCR-ABL - LSK (%) P value vs. BCR-ABL + LKS - P value vs. BCR-ABL - LSK CD2 RM2-5 12.9 ± 3.6 36.7 ± 6.5 19.3 ± 2.4 0.01 0.10 CD5 53-7.3 13.9 ± 3.2 20.8
More informationMyeloproliferative Disorders - D Savage - 9 Jan 2002
Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2
More informationThe Immune System. A macrophage. ! Functions of the Immune System. ! Types of Immune Responses. ! Organization of the Immune System
The Immune System! Functions of the Immune System! Types of Immune Responses! Organization of the Immune System! Innate Defense Mechanisms! Acquired Defense Mechanisms! Applied Immunology A macrophage
More informationHaematopoietic stem cells
Haematopoietic stem cells Neil P. Rodrigues, DPhil NIH Centre for Biomedical Research Excellence in Stem Cell Biology Boston University School of Medicine neil.rodrigues@imm.ox.ac.uk Haematopoiesis: An
More informationCHAPTER 3 LABORATORY PROCEDURES
CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES 3.1 HLA TYPING Molecular HLA typing will be performed for all donor cord blood units and patients in the three reference laboratories identified
More informationSupporting Information
Supporting Information Desnues et al. 10.1073/pnas.1314121111 SI Materials and Methods Mice. Toll-like receptor (TLR)8 / and TLR9 / mice were generated as described previously (1, 2). TLR9 / mice were
More informationMast Cell Disease Case 054 Session 7
Mast Cell Disease Case 054 Session 7 Rodney R. Miles, M.D., Ph.D. Lauren B. Smith, M.D. Cem Akin, M.D. Diane Roulston,, Ph.D. Charles W. Ross, M.D. Departments of Pathology and Internal Medicine University
More informationHematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF).
Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte colony-stimulating factor(g-csf). Granulocyte-macrophage colonystimulating factor (G-CSF). Interleukin-11
More informationSupplemental Information. Granulocyte-Monocyte Progenitors and. Monocyte-Dendritic Cell Progenitors Independently
Immunity, Volume 47 Supplemental Information Granulocyte-Monocyte Progenitors and Monocyte-endritic ell Progenitors Independently Produce Functionally istinct Monocytes lberto Yáñez, Simon G. oetzee, ndre
More informationHematology Unit Lab 2 Review Material
Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
More informationGranulocyte Colony-Stimulating Factor in Acute Myeloid Leukemia
Granulocyte Colony-Stimulating Factor in Acute Myeloid Leukemia Kensuke Usuki," Seiko Iki," Mitsue Endo," Koichi Kitazume," Keiko Ito," Masahiko Watanabe,b Akio Urabea "Division of Hematology, Kanto Teishin
More informationExpression of TRAIL and its receptor DR5 and their significance in acute leukemia cells
Expression of TRAIL and its receptor DR5 and their significance in acute leukemia cells S.M. Chen, H. Sun, Y.F. Liu, J. Ma, Q.T. Zhang, J. Zhu and T. Li Department of Hematology, The First Affiliated Hospital
More informationS been applied to the study of the biology of normal
Application of In Vitro Soft Agar Techniques for Growth of Tumor Cells to the Study of Colon Cancer RONALD N. BUICK, PHD,* STEPHEN E. FRY, MS,t AND SYDNEY E. SALMON, MD$ An in vitro assay to measure the
More informationMATERIALS AND METHODS. Cells and cell separation INTRODUCTION. Li Lu,* Zhi-Hua Li,* Jie He,* Yue Ge,* Susan Rice, and Hal E.
Transduction of recombinant human erythropoietin receptor cdna into daughter progenitors derived from single CD34 3 cord blood cells changes the differentiation profile of daughter progenitors Li Lu,*
More informationEffective Targeting of Quiescent Chronic Myelogenous
Cancer Cell, Volume 7 Supplemental Information Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate Bin Zhang,
More informationBiological Activities of Human Granulocyte- Macrophage Colony-Stimulating Factor
Concise Review International Journal of Cell Cloning 6:365-377 (1988) Biological Activities of Human Granulocyte- Macrophage Colony-Stimulating Factor Steven C. Clark Genetics Institute, Cambridge, Massachusetts,
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature11095 Supplementary Table 1. Summary of the binding between Angptls and various Igdomain containing receptors as determined by flow cytometry analysis. The results were summarized from
More informationAplastic anemia. Case report. Effect of antithymocyte globulin on erythroid colony formation
Case report Aplastic anemia Effect of antithymocyte globulin on erythroid colony formation Susan A. Rothmann Hamburger, Ph.D. Department of Laboratory Hematology and Blood Banking James H. Finke, Ph.D.
More informationPathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16
35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will
More informationSunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic
Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myeogenouse leukemia cells that is enhanced by 1,25-dihydroxyviatmin D 3. To the Editor: Sunitinib,
More informationToluidin-Staining of mast cells Ear tissue was fixed with Carnoy (60% ethanol, 30% chloroform, 10% acetic acid) overnight at 4 C, afterwards
Toluidin-Staining of mast cells Ear tissue was fixed with Carnoy (60% ethanol, 30% chloroform, 10% acetic acid) overnight at 4 C, afterwards incubated in 100 % ethanol overnight at 4 C and embedded in
More informationHuman chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
Research article Related Commentary, page 22 Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity Amie S. Corbin, 1,2 Anupriya Agarwal, 1 Marc Loriaux,
More informationAETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa
More informationFeasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas
University of Groningen Feasibility of hyperthermia as a purging modality in autologous bone marrow transplantation Wierenga, Pieter Klaas IMPORTANT NOTE: You are advised to consult the publisher's version
More informationPersonalized Therapy for Acute Myeloid Leukemia. Patrick Stiff MD Loyola University Medical Center
Personalized Therapy for Acute Myeloid Leukemia Patrick Stiff MD Loyola University Medical Center 708-327-3216 Major groups of Mutations in AML Targets for AML: Is this Achievable? Chronic Myeloid Leukemia:
More informationCitation Acta medica Nagasakiensia. 1991, 36
NAOSITE: Nagasaki University's Ac Title Author(s) Induction of Killer Activity in Per Chemotherapy with Methotrexate, Vin (M-VAC) Taniguchi, Keisuke Citation Acta medica Nagasakiensia. 1991, 36 Issue Date
More informationHematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD
Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,
More informationSH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL
SH2017-0124 A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL NEGATIVE John R Goodlad 1, Pedro Martin-Cabrera 2, Catherine Cargo 2 1. Department of Pathology, NHS Greater Glasgow & Clyde, QEUH, Glasgow 2. Haematological
More informationFlow Cytometry. What is flow cytometry?
Flow Cytometry Flow Cytometry What is flow cytometry? Flow cytometry is a popular laser-based technology to analyze the characteristics of cells or particles. It is predominantly used to measure fluorescence
More informationSUPPLEMENTARY INFORMATION GENOTOXICITY. In vitro Genotoxicity Studies
SUPPLEMENTARY INFORMATION GENOTOXICITY In vitro Genotoxicity Studies The in vitro immortalisation (IVIM) assay relies on the induction of a survival advantage by insertional activation of cellular proto-oncogenes,
More informationPRODUCTS FOR CANCER RESEARCH
PRODUCTS FOR CANCER RESEARCH TABLE OF CONTENTS 3 4 6 10 11 12 Introduction ALDEFLUOR A Powerful Tool to Study Cancer Stem Cells Culture Media for Cancer Research Culture Media Products for Breast Cancer
More informationSUPPLEMENTARY INFORMATION. CXCR4 inhibitors could benefit to HER2 but not to Triple-Negative. breast cancer patients
SUPPLEMENTARY INFORMATION CXCR4 inhibitors could benefit to HER2 but not to Triple-Negative breast cancer patients Lefort S. 1,2, Thuleau A. 3, Kieffer Y. 1,2, Sirven P. 1,2, Bieche I. 4, Marangoni E.
More informationJournal of the Egyptian Nat. Cancer Inst., Vol. 13, No. 3, September: , 2001
Journal of the Egyptian Nat. Cancer Inst., Vol. 13, No. 3, September: 191-201, 2001 Expression of the C-KIT Molecule in Acute Myeloid Leukemias: Implications of the Immunophenotypes CD117 and CD15 in the
More informationQuestion 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?
Abbas Chapter 2: Sarah Spriet February 8, 2015 Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? a. Dendritic cells b. Macrophages c. Monocytes
More informationSupplementary Figure 1. Characterization of basophils after reconstitution of SCID mice
Supplementary figure legends Supplementary Figure 1. Characterization of after reconstitution of SCID mice with CD4 + CD62L + T cells. (A-C) SCID mice (n = 6 / group) were reconstituted with 2 x 1 6 CD4
More informationMyeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients to Benefit from Transplant
Original Article http://dx.doi.org/1349/ymj.212.53.3.53 pissn: 513-5796, eissn: 1976-2437 Yonsei Med J 53(3):53-536, 212 Myeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients
More informationKey Words. Diamond-Blackfan anemia M-07e cell line Stem cell factor GM-CSF Bone marrow fibroblast Long-term bone marrow cultures Stromal cells
M-07e Cell Bioassay Detects Stromal Cell Production of Granulocyte-Macrophage Colony Stimulating Factor and Stem Cell Factor in Normal and in Diamond-Blackfan Anemia Bone Marrow Laura Bonsi," Gian Paolo
More informationJAK2 V617F analysis. Indication: monitoring of therapy
JAK2 V617F analysis BCR-ABL genotyping The exact chromosomal defect in Philadelphia chromosome is a translocation. Parts of two chromosomes, 9 and 22, switch places. The result is a fusion gene, created
More informationD Bonnet 1,2, M Bhatia 1,3, JCY Wang 1, U Kapp 1 and JE Dick 1. Summary:
Bone Marrow Transplantation, (1999) 23, 203209 1999 Stockton Press All rights reserved 02683369/99 $12.00 http://www.stockton-press.co.uk/bmt Cytokine treatment or accessory cells are required to initiate
More informationCorporate Medical Policy. Policy Effective February 23, 2018
Corporate Medical Policy Genetic Testing for FLT3, NPM1 and CEBPA Mutations in Acute File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_flt3_npm1_and_cebpa_mutations_in_acute_myeloid_leukemia
More informationA CD123-targeting Antibody-Drug Conjugate (ADC), IMGN632, designed to eradicate Acute Myeloid Leukemia (AML) cells while sparing normal bone marrow
A CD123-targeting Antibody-Drug Conjugate (ADC), IMGN632, designed to eradicate Acute Myeloid Leukemia (AML) cells while sparing normal bone marrow Yelena Kovtun, Gregory Jones, Charlene Audette, Lauren
More information& 2005 Nature Publishing Group All rights reserved /05 $
(25), 183 188 & 25 Nature Publishing Group All rights reserved 28-39/5 $ www.nature.com/bmt Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic
More informationMeeting Report. From December 8 to 11, 2012 at Atlanta, GA, U.S.A
Meeting Report Affiliation Department of Transfusion Medicine and Cell Therapy Name Hisayuki Yao Name of the meeting Period and venue Type of your presentation Title of your presentation The 54 th Annual
More informationRCPA Research Award Final Progress Review
RCPA Research Award 2010-2011 Final Progress Review Name: Dr Craig Wallington-Beddoe Degree/Institution/Year: PhD, The University of Sydney, Year 2 Research Project Title: New Therapeutic Strategies for
More informationSignaling changes in the stem cell factor AKT-S6 pathway in diagnostic AML samples are associated with disease relapse
LETTER TO THE EDITOR Citation: (2011) 1, e3; doi:10.1038/bcj.2010.2 & 2011 Macmillan Publishers Limited All rights reserved 2044-5385/11 www.nature.com/bcj Signaling changes in the stem cell factor AKT-S6
More informationFLT3/FLK2 Ligand Promotes the Growth of Murine Stem Cells and the Expansion of Colony-Forming Cells and Spleen Colony-Forming Units
FLT3/FLK2 Ligand Promotes the Growth of Murine Stem Cells and the Expansion of Colony-Forming Cells and Spleen Colony-Forming Units By Susan Hudak, Brisdell Hunte, Janice Culpepper, Satish Menon, Charles
More informationNUP214-ABL1 Fusion: A Novel Discovery in Acute Myelomonocytic Leukemia
Case 0094 NUP214-ABL1 Fusion: A Novel Discovery in Acute Myelomonocytic Leukemia Jessica Snider, MD Medical University of South Carolina Case Report - 64 year old Caucasian Male Past Medical History Osteoarthritis
More informationTreatment of low risk MDS
Treatment of low risk MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy matteo.della_porta@hunimed.eu International Prognostic Scoring
More informationMouse Hematopoietic Stem Cells and the Interaction of c-kit Receptor and Steel Factor
Concise Review International Journal of Cell Cloning 9:451-460 (1991) Mouse Hematopoietic Stem Cells and the Interaction of c-kit Receptor and Steel Factor kbichi Ikuta", Diane E. Ingoliaq JdFriedman",
More informationMonocyte subsets in health and disease. Marion Frankenberger
Monocyte subsets in health and disease Marion Frankenberger main cellular components: Leukocytes Erythrocytes Composition of whole blood Monocytes belong to the cellular components of peripheral blood
More informationSupervisor: Prof. Dr. P Vandenberghe Dr. C Brusselmans
Contribution of molecular diagnosis in eosinophilia/hypereosinophilia Eosinophilia Hypereosinophilia Hypereosinophilic syndrome Immune mediated hypereosinophilia Chronic eosinophilic leukemia (NOS)/ Idiopathic
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/23854 holds various files of this Leiden University dissertation. Author: Marel, Sander van der Title: Gene and cell therapy based treatment strategies
More informationHemoglobin F synthesis in vitro: Evidence for control
Proc. Natl. Acad. Sci. USA Vol. 74, No. 7, pp. 2923-2927, July 1977 Cell Biology Hemoglobin F synthesis in vitro: Evidence for control at the level of primitive erythroid stem cells (Hb F regulation/erythroid
More informationMolecular Hematopathology Leukemias I. January 14, 2005
Molecular Hematopathology Leukemias I January 14, 2005 Chronic Myelogenous Leukemia Diagnosis requires presence of Philadelphia chromosome t(9;22)(q34;q11) translocation BCR-ABL is the result BCR on chr
More informationCURRICULUM VITAE. RON D. SCHIFF, M..D., Ph.D. May 26, 2015
CURRICULUM VITAE RON D. SCHIFF, M..D., Ph.D. May 26, 2015 ADDRESS: 6625 Stonington Drive Tampa, Florida 33647 RSchiff@SchiffBiomedicalConsulting.com TELEPHONE NUMBERS: Office (813) 978-8327 Cell (813)
More informationProduction of the Formed Elements (Chapter 11) *
OpenStax-CNX module: m62120 1 Production of the Formed Elements (Chapter 11) * Ildar Yakhin Based on Production of the Formed Elements by OpenStax This work is produced by OpenStax-CNX and licensed under
More informationRole of the Colony-Stimulating Factor-l Receptor (c-fms) and Its Ligand in Oncogenesis
Role of the Colony-Stimulating Factor-l Receptor (c-fms) and Its Ligand in Oncogenesis C.W. Rettenmier A. Introduction An increasing body of experimental evidence supports the concept that malignant cell
More information